Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 62

1.

Health Disparities Among Children with Asthma in the United States by Place of Residence.

Sullivan PW, Ghushchyan V, Kavati A, Navaratnam P, Friedman HS, Ortiz B.

J Allergy Clin Immunol Pract. 2019 Jan;7(1):148-155. doi: 10.1016/j.jaip.2018.05.001. Epub 2018 May 18.

PMID:
29782937
2.

The national burden of poorly controlled asthma, school absence and parental work loss among school-aged children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Asthma. 2018 Jun;55(6):659-667. doi: 10.1080/02770903.2017.1350972. Epub 2017 Oct 5.

PMID:
28981368
3.

Estimating asthma control questionnaire (ACQ) scores from claims data.

Sullivan PW, Ghushchyan VH, Globe G.

J Asthma. 2018 Sep;55(9):1002-1010. doi: 10.1080/02770903.2017.1386670. Epub 2017 Oct 30.

PMID:
28976789
4.

The national cost of asthma among school-aged children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

Ann Allergy Asthma Immunol. 2017 Sep;119(3):246-252.e1. doi: 10.1016/j.anai.2017.07.002.

PMID:
28890020
5.

National Prevalence of Poor Asthma Control and Associated Outcomes Among School-Aged Children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):536-544.e1. doi: 10.1016/j.jaip.2017.06.039. Epub 2017 Aug 26.

PMID:
28847656
6.

Indicators of poorly controlled asthma and health-related quality of life among school-age children in the United States.

Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B.

Allergy Asthma Proc. 2017 Nov 11;38(6):431-439. doi: 10.2500/aap.2017.38.4084. Epub 2017 Aug 11.

PMID:
28800789
7.

Oral corticosteroid exposure and adverse effects in asthmatic patients.

Sullivan PW, Ghushchyan VH, Globe G, Schatz M.

J Allergy Clin Immunol. 2018 Jan;141(1):110-116.e7. doi: 10.1016/j.jaci.2017.04.009. Epub 2017 Apr 27.

PMID:
28456623
8.

EQ-5D Scores for Diabetes-Related Comorbidities.

Sullivan PW, Ghushchyan VH.

Value Health. 2016 Dec;19(8):1002-1008. doi: 10.1016/j.jval.2016.05.018. Epub 2016 Jul 15.

9.

Health-related quality of life associated with systemic corticosteroids.

Sullivan PW, Ghushchyan VH, Globe G, Sucher B.

Qual Life Res. 2017 Apr;26(4):1037-1058. doi: 10.1007/s11136-016-1435-y. Epub 2016 Oct 18.

PMID:
27757775
10.

Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire.

Sullivan PW, Globe G, Ghushchyan VH, Campbell JD, Bender B, Magid DJ.

Ann Allergy Asthma Immunol. 2016 Sep;117(3):251-257.e2. doi: 10.1016/j.anai.2016.07.020.

PMID:
27613458
11.

Measurement of utility in asthma: evidence indicating that generic instruments may miss clinically important changes.

Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ.

Qual Life Res. 2016 Dec;25(12):3017-3026. Epub 2016 Jul 7.

PMID:
27387417
12.

Measuring the cost of poor asthma control and exacerbations.

Sullivan PW, Ghushchyan VH, Campbell JD, Globe G, Bender B, Magid DJ.

J Asthma. 2017 Jan 2;54(1):24-31. doi: 10.1080/02770903.2016.1194430. Epub 2016 Jun 10.

PMID:
27286240
13.

Measuring the effect of asthma control on exacerbations and health resource use.

Sullivan PW, Campbell JD, Globe G, Ghushchyan VH, Bender B, Schatz M, Chon Y, Woolley JM, Magid DJ.

J Allergy Clin Immunol. 2015 Nov;136(5):1409-11.e1-6. doi: 10.1016/j.jaci.2015.04.046. Epub 2015 Jun 12. No abstract available.

PMID:
26073753
14.

Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma.

Sullivan PW, Campbell JD, Ghushchyan VH, Globe G.

Ann Allergy Asthma Immunol. 2015 Jun;114(6):462-9. doi: 10.1016/j.anai.2015.03.019. Epub 2015 Apr 15.

PMID:
25890451
15.

Characterizing the severe asthma population in the United States: claims-based analysis of three treatment cohorts in the year prior to treatment escalation.

Sullivan PW, Campbell JD, Ghushchyan VH, Globe G, Lange J, Woolley JM.

J Asthma. 2015 Sep;52(7):669-80. doi: 10.3109/02770903.2015.1004683.

PMID:
25731600
16.

Dynamic medication adherence modeling in primary prevention of cardiovascular disease: a Markov microsimulation methods application.

Slejko JF, Sullivan PW, Anderson HD, Ho PM, Nair KV, Campbell JD.

Value Health. 2014 Sep;17(6):725-31. doi: 10.1016/j.jval.2014.06.010. Epub 2014 Jul 28.

17.

The relationship between asthma, asthma control and economic outcomes in the United States.

Sullivan PW, Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin SL, Globe G.

J Asthma. 2014 Sep;51(7):769-78. doi: 10.3109/02770903.2014.906607. Epub 2014 Apr 7.

PMID:
24697738
18.

Adherence to statins in primary prevention: yearly adherence changes and outcomes.

Slejko JF, Ho M, Anderson HD, Nair KV, Sullivan PW, Campbell JD.

J Manag Care Pharm. 2014 Jan;20(1):51-7.

19.

Asthma control in the United States, 2008-2010: indicators of poor asthma control.

Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin SL, Globe G, Sullivan PW.

J Allergy Clin Immunol. 2014 Jun;133(6):1579-87. doi: 10.1016/j.jaci.2013.10.028. Epub 2013 Dec 10.

PMID:
24331376
20.

Asthma in USA: its impact on health-related quality of life.

Sullivan PW, Smith KL, Ghushchyan VH, Globe DR, Lin SL, Globe G.

J Asthma. 2013 Oct;50(8):891-9. doi: 10.3109/02770903.2013.813035. Epub 2013 Jul 11.

PMID:
23815682

Supplemental Content

Loading ...
Support Center